Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines and providing hope to people living with cancer, neurologic and autoimmune disease. Deciphera is leveraging its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from Deciphera’s platform in clinical studies, QINLOCK® (ripretinib) is Deciphera’s switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib. ROMVIMZA® (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability.    The spirit of collaboration that has brought medications to life continues to guide how we operate, grow, and discover new breakthroughs. We cultivate an inclusive culture that values curiosity, creativity, and shared accountability—empowering individuals to challenge the unknown together.  Deciphera offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes medical, dental, vision, 401(k) retirement plan, life insurance and a flexible spending account for either health care and/or dependent care.  The Associate Director, Commercial Finance will manage the company’s Commercial Finance activities and serve as a key finance partner to the Commercial organization. The role will support the company’s commercial products, including QINLOCK and ROMVIMZA, while helping prepare the organization for multiple product launches planned over the next several years. This individual will oversee revenue forecasting and reporting, gross-to-net, budgeting and forecasting, long-range planning, commercial investment analysis, launch planning and performance analysis. The Associate Director will work closely with Commercial and Finance stakeholders to provide actionable insights supporting business decisions and will manage and develop the Commercial Finance team. This is a hands-on role with regular interaction across Deciphera and corporate headquarters. The successful candidate will bring strong biopharmaceutical Commercial Finance experience together with analytical, business partnering, communication and people management skills. Key Responsibilities: Commercial Finance Leadership and Business Partnership 100%              • Serve as a key Finance partner to the Commercial organization, providing analysis, guidance and insights to support strategic and operational decision-making. • Manage Commercial financial planning activities, including annual budgeting, forecasts, long-range planning and ongoing performance analysis. • Oversee revenue forecasting and performance reporting, including analysis of actual results against forecast and guidance. • Partner closely with Accounting and Commercial stakeholders on revenue recognition, gross-to-net assumptions and reporting, including government rebates, returns reserves and other adjustments to revenue. • Provide financial analysis and decision support for current and future product launches, including scenario planning, investment decisions, resource allocation and assessment of post-launch performance. • Partner with Commercial leadership and functional teams, including Sales, Marketing, Market Access and Commercial Operations, on financial and strategic initiatives, including pricing dynamics and contract administration. • Prepare and deliver key financial analyses and presentations to Commercial and Finance leadership and corporate headquarters, including support for earnings and other management reporting. • Collaborate with cross-functional partners through the S&OP process to align commercial forecasts with supply planning and ensure continuity of supply. • Lead, coach and develop members of the Commercial Finance team, fostering strong business partnership, analytical capabilities and professional development. • Manage special projects and analyses that bring a financial and analytical perspective to decision-making and drive continuous improvement. Other duties and responsibilities as assigned • Bachelor’s degree in Finance, Accounting, Economics, Business Administration, or a related field. • Minimum of 8 years of relevant Finance experience, including meaningful Commercial Finance, FP&A, or related experience within the biopharmaceutical or pharmaceutical industry. • Strong understanding of pharmaceutical commercialization and key financial drivers, including revenue forecasting, gross-to-net, operating expense management, and financial planning and analysis. • Experience partnering with Commercial stakeholders and providing financial analysis and insights to support business decisions. • Demonstrated people leadership skills, including experience managing and developing Finance professionals. • Excellent analytical, financial modeling, communication, and presentation skills, including the ability to communicate effectively with business leaders and corporate headquarters. Preferred Capabilities • Experience supporting commercial product launches and/or products at various stages of commercialization. • Proven ability to develop